Selected developments from primary sources, with clear evidence stages and questions to resolve before considering treatment in India.
Sources last checked: · Blue Crescent
On this page
Surgical technology · explanation and availability checks
da Vinci 5: the next generation of robotic-assisted surgery
Enhanced 3D vision and Force Feedback with compatible instruments, controlled by the surgeon. Explore potential benefits, limitations and availability.
The supplied Max announcement names Max Super Speciality Hospital, Saket, New Delhi, and Nanavati Max Super Speciality Hospital, Mumbai. That announcement is the source of this availability update. Confirm da Vinci 5, the procedure, surgeon and appointment directly with the branch before travel or payment.
FDA expanded Anktiva with BCG to adults with BCG-unresponsive non-muscle-invasive bladder cancer including high-grade papillary-only tumours. Delaying cystectomy can be dangerous; discuss the decision with a specialist.
India availability for this use: not confirmed by us.
US approval covers adjuvant atezolizumab with a fluoropyrimidine and oxaliplatin for stage III dMMR colon cancer. Tumour testing matters. Immune-mediated reactions can be serious.
India availability for this use: not confirmed by us.
FDA approved tucatinib with trastuzumab and pertuzumab after induction for adults with unresectable locally advanced or metastatic HER2-positive breast cancer. Liver toxicity and diarrhoea require attention.
India availability for this use: not confirmed by us.
TDB announced support for BCMA/CD19-targeting CAR-T development for multiple myeloma, with a planned phase I trial. The announcement does not establish treatment results or product approval.
The announcement does not establish recruitment or routine availability.
